12 Health Care Stocks Moving In Wednesday's After-Market Session
Portfolio Pulse from Benzinga Insights
In Wednesday's after-market session, several healthcare stocks experienced significant movements. Reshape Lifesciences, Semler Scientific, China Pharma Holding, CARISMA Therapeutics, Purple Biotech, and Sangamo Therapeutics saw gains, while 180 Life Sciences, Cartesian Therapeutics, Alpha Tau Medical, Cogent Biosciences, Exicure, and NewAmsterdam Pharma faced declines. The changes in stock prices are attributed to market activities, with no specific news driving the movements.
January 10, 2024 | 9:31 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
180 Life Sciences shares fell 18.2% to $0.25, with a market cap of $2.4 million.
The significant drop in ATNF's stock price could lead to a negative short-term impact as investors react to the decline.
CONFIDENCE 70
IMPORTANCE 60
RELEVANCE 80
NEGATIVE IMPACT
Cogent Biosciences stock fell 6.2% to $5.0, with a market cap of $430.6 million.
COGT's stock price decrease may continue to impact it negatively in the short term as market sentiment appears to be bearish.
CONFIDENCE 70
IMPORTANCE 60
RELEVANCE 80
NEGATIVE IMPACT
Alpha Tau Medical stock fell 7.28% to $3.06, with a market cap of $212.5 million.
The decline in DRTS's stock price could indicate a bearish short-term trend, affecting investor confidence.
CONFIDENCE 70
IMPORTANCE 60
RELEVANCE 80
NEGATIVE IMPACT
NewAmsterdam Pharma shares fell 5.4% to $16.3, with a market cap of $1.3 billion.
NAMS's stock price drop could negatively affect investor sentiment in the short term, leading to potential further declines.
CONFIDENCE 70
IMPORTANCE 60
RELEVANCE 80
NEGATIVE IMPACT
Cartesian Therapeutics shares decreased by 9.74% to $0.74, with a market cap of $119.1 million.
RNAC's after-market drop may reflect investor concerns, potentially leading to further short-term declines.
CONFIDENCE 70
IMPORTANCE 60
RELEVANCE 80
NEGATIVE IMPACT
Exicure shares declined by 5.47% to $0.74, with a market value of their outstanding shares at $6.4 million.
The negative movement in XCUR's stock price could suggest a bearish outlook, potentially leading to further short-term declines.
CONFIDENCE 70
IMPORTANCE 50
RELEVANCE 80
POSITIVE IMPACT
CARISMA Therapeutics stock rose 5.07% to $2.9, with a market cap of $117.0 million.
The increase in CARM's stock price may indicate a positive short-term outlook, potentially leading to further gains.
CONFIDENCE 70
IMPORTANCE 50
RELEVANCE 80
POSITIVE IMPACT
China Pharma Holding stock increased by 5.82% to $0.1, with a market cap of $3.2 million.
CPHI's after-market gain suggests a potential short-term positive trend, although the low market cap may indicate higher volatility.
CONFIDENCE 70
IMPORTANCE 50
RELEVANCE 80
POSITIVE IMPACT
Purple Biotech stock increased by 4.99% to $0.7, with a market cap of $17.2 million.
PPBT's stock price movement could suggest investor optimism, potentially leading to a short-term positive impact.
CONFIDENCE 70
IMPORTANCE 50
RELEVANCE 80
POSITIVE IMPACT
Reshape Lifesciences stock increased by 6.7% to $0.26, with a market cap of $4.8 million.
The after-market gain for RSLS could attract investor interest, potentially leading to a short-term positive impact on the stock price.
CONFIDENCE 70
IMPORTANCE 50
RELEVANCE 80
POSITIVE IMPACT
Sangamo Therapeutics shares increased by 4.99% to $0.58, with a market cap of $102.4 million.
The uptick in SGMO's stock price may continue short-term, reflecting a positive investor sentiment.
CONFIDENCE 70
IMPORTANCE 50
RELEVANCE 80
POSITIVE IMPACT
Semler Scientific shares rose 5.99% to $52.87, with a market cap of $363.3 million.
The positive movement in SMLR's stock price may continue into the next trading session, reflecting a short-term bullish sentiment.
CONFIDENCE 70
IMPORTANCE 50
RELEVANCE 80